Rosalind Advisors Inc's Q1 2026 13F: 11 new positions, 8 exits

Form 13F-HR for the quarter ended Mar 31, 2026 · filed May 14, 2026 · 32 reported positions · accession 0001622627-26-000015

What changed this quarter

Rosalind Advisors Inc's changes in reported equity positions, Q1 2026
Activity Security Weight before Weight now Change Shares Shares %
New VAXCYTE INC (PCVX) — 6.9% +6.9 pts +290K sh new
Reduced CG ONCOLOGY INC (CGON) 4.5% 2.8% −1.8 pts −200K sh −67%
New VOR BIOPHARMA INC (VOR) — 5.1% +5.1 pts +700K sh new
Exited REPLIMUNE GROUP INC (REPL) 5.0% — −5.0 pts −1.41M sh −100%
Exited ASTRIA THERAPEUTICS INC (ATYR) 5.0% — −5.0 pts −1.04M sh −100%
Exited CYTOKINETICS INC (CYTK) 4.5% — −4.5 pts −195K sh −100%
New CELLDEX THERAPEUTICS INC (CLDX) — 4.3% +4.3 pts +330K sh new
Exited MIND MEDICINE MINDMED INC (MNMD) 3.7% — −3.7 pts −750K sh −100%
New BIOCRYST PHARMACEUTICALS INC (BCRX) — 3.6% +3.6 pts +923K sh new
Increased XERIS BIOPHARMA HOLDINGS INC (XERS) 6.0% 7.7% +1.6 pts +1.12M sh +53%
New ATEA PHARMACEUTICALS INC (AVIR) — 2.6% +2.6 pts +1.17M sh new
Increased EYEPOINT PHARMACEUTICALS INC (EYPT) 4.6% 5.5% +0.9 pts +347K sh +50%
Exited Ocular Therapeutix, Inc (OCUL) 1.8% — −1.8 pts −400K sh −100%
Reduced VIRIDIAN THERAPEUTICS INC (VRDN) 5.1% 2.0% −3.1 pts −200K sh −44%
Exited ARRIVENT BIOPHARMA INC (AVBP) 1.6% — −1.6 pts −216K sh −100%
Increased X4 PHARMACEUTICALS INC (XFOR) 3.8% 5.4% +1.6 pts +609K sh +23%
New OVID THERAPEUTICS INC (OVID) — 1.0% +1.0 pts +1.11M sh new
New DEFINIUM THERAPEUTICS INC (DFTX) — 1.0% +1.0 pts +125K sh new
Increased VERASTEM INC (VSTM) 5.0% 4.6% −0.4 pts +350K sh +20%
Increased FENNEC PHARMACEUTICALS INC (FENC) 7.3% 7.3% 0.0 pts +295K sh +11%
New LIPOCINE INC (LPCN) — 0.7% +0.7 pts +222K sh new
Reduced PROFOUND MEDICAL CORP (PROF) 3.1% 2.2% −0.9 pts −241K sh −23%
Reduced ONKURE THERAPEUTICS INC (OKUR) 0.8% 0.8% 0.0 pts −287K sh −39%
New AVALO THERAPEUTICS INC (AVTX) — 0.5% +0.5 pts +75,000 sh new
Exited TREVI THERAPEUTICS INC (TRVI) 0.5% — −0.5 pts −100K sh −100%
New ANNEXON INC (ANNX) — 0.5% +0.5 pts +200K sh new
Reduced SAVARA INC (SVRA) 7.5% 7.2% −0.3 pts −200K sh −6%
New AQUESTIVE THERAPEUTICS INC (AQST) — 0.4% +0.4 pts +250K sh new
Exited FRACTYL HEALTH INC (GUTS) 0.3% — −0.3 pts −386K sh −100%
Reduced CYBIN INC (CYBN) 4.9% 3.0% −1.9 pts −126K sh −8%
Reduced POLYPID LTD (PYPD) 1.1% 1.1% 0.0 pts −98,630 sh −14%
Reduced TALPHERA INC (TLPH) 1.5% 1.0% −0.5 pts −225K sh −6%
Increased BIOFRONTERA INC (BFRI) 0.2% 0.4% +0.1 pts +23,198 sh +2%
Increased MYOMO INC (MYO) 1.3% 1.1% −0.2 pts +7,500 sh 0%

Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled

Top 10 positions — 67.2% of the equity book

Changes in the top 10 this quarter: PCVX entered · EYPT entered · XFOR entered · VOR entered · VRDN left · REPL left · ATYR left · CYBN left

# Security Weight before Weight now
1 DELCATH SYSTEMS, INC. (DCTH) 12.0% 12.5%
2 XERIS BIOPHARMA HOLDINGS INC (XERS) 6.0% 7.7%
3 FENNEC PHARMACEUTICALS INC (FENC) 7.3% 7.3%
4 SAVARA INC (SVRA) 7.5% 7.2%
5 VAXCYTE INC (PCVX) 0.0% 6.9% Entered the top 10
6 EYEPOINT PHARMACEUTICALS INC (EYPT) 4.6% 5.5% Entered the top 10
7 X4 PHARMACEUTICALS INC (XFOR) 3.8% 5.4% Entered the top 10
8 VOR BIOPHARMA INC (VOR) 0.0% 5.1% Entered the top 10
9 MEDIWOUND LTD (MDWD) 5.0% 4.9%
10 VERASTEM INC (VSTM) 5.0% 4.6%
— VIRIDIAN THERAPEUTICS INC (VRDN) 5.1% 2.0% Left the top 10
— REPLIMUNE GROUP INC (REPL) 5.0% 0.0% Left the top 10
— ASTRIA THERAPEUTICS INC (ATYR) 5.0% 0.0% Left the top 10
— CYBIN INC (CYBN) 4.9% 3.0% Left the top 10

Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).

Option positions (puts and calls)

Reported separately from the positions above. The value a 13F reports for an option is that of the underlying shares, not the option itself.

Activity Security Type Shares before Shares now Reported value
Increased REPLIMUNE GROUP INC (REPL) Call 231K 1.28M $2.75M
Reduced INVESCO QQQ TR (QQQ) Put 450K 250K $1.05M
Exited ANAVEX LIFE SCIENCES CORP (AVXL) Put 1.17M 0 $0
Exited SPDR SERIES TRUST (BIL) Put 1.94M 0 $0
Exited ISHARES TR (NYC) Put 200K 0 $0
Reduced SPDR S&P 500 ETF TR (SPY) Put 510K 125K $959K
Increased ARRIVENT BIOPHARMA INC (AVBP) Call 108K 109K $0
Exited VERASTEM INC (VSTM) Call 269K 0 $0
Increased UNIQURE NV (QURE) Call 100K 296K $0
New VIRIDIAN THERAPEUTICS INC (VRDN) Put 0 264K $52.7K
Exited VIKING THERAPEUTICS INC (VKTX) Call 100K 0 $0
Exited REPLIMUNE GROUP INC (REPL) Put 265K 0 $0
Exited REZOLUTE INC (RZLT) Call 263K 0 $0
Exited VISTAGEN THERAPEUTICS INC (VSTA) Call 493K 0 $0